In This Article:
ST. HELIER, Jersey (AP) — ST. HELIER, Jersey (AP) — NovoCure Ltd. (NVCR) on Thursday reported a loss of $65.9 million in its fourth quarter.
The St. Helier, Jersey-based company said it had a loss of 61 cents per share.
The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 34 cents per share.
The oncology drug developer posted revenue of $161.3 million in the period, which met Street forecasts.
For the year, the company reported a loss of $168.6 million, or $1.56 per share. Revenue was reported as $605.2 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NVCR at https://www.zacks.com/ap/NVCR